Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Swedish Cancer Foundation | OTHER |
| Medical Research Council | OTHER_GOV |
The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.
Randomized study with follow up evaluations each month until preterminal state. Cancer patients will be randomised to either high dose or low dose of active treatment given as daily injection.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A, 1 | Active Comparator | Ghrelin |
|
| A, 2 | Active Comparator | Ghrelin. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ghrelin | Drug | High dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Food intake | June 2008 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kent Lundholm, MD, prof | Göteborg University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of surgery, Sahlgrenska University Hospital | Gothenburg | 413 45 | Sweden |
Not provided
| Label | URL |
|---|---|
| Göteborg University | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054439 | Ghrelin |
| ID | Term |
|---|---|
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ghrelin | Drug | Low dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks. |
|
| D000602 | Amino Acids, Peptides, and Proteins |